how to become a scholar

Source

Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.

Very Positive
Positive
Neutral
Negative
Very Negative

Source	Headline
	Zacks: Brokerages Expect Scholar Rock Holding Co. (NASDAQ:SRRK) Will Announce Quarterly Sales of $4.40 Million americanbankingnews.com - November 3 at 2:57 AM
	Earnings Preview: Scholar Rock Holding Corporation (SRRK) Q3 Earnings Expected to Decline finance.yahoo.com - November 1 at 6:44 PM
	Analysts Anticipate Scholar Rock Holding Co. (NASDAQ:SRRK) to Announce -$0.85 Earnings Per Share americanbankingnews.com - November 1 at 1:12 PM
	Reviewing Scholar Rock (NASDAQ:SRRK) & Clarus Therapeutics (NASDAQ:CRXT) americanbankingnews.com - October 19 at 5:22 AM
	Zacks: Brokerages Expect Scholar Rock Holding Co. (NASDAQ:SRRK) Will Post Quarterly Sales of $4.40 Million americanbankingnews.com - October 15 at 2:32 AM
	Scholar Rock Holding Co. (NASDAQ:SRRK) Expected to Post Earnings of -$0.85 Per Share americanbankingnews.com - October 13 at 5:10 PM
	Scholar Rock (NASDAQ:SRRK) Shares Gap Up to $28.02 americanbankingnews.com - October 12 at 1:14 PM
	Scholar Rock Holding Insider Sold $185K In Company Stock finance.yahoo.com - October 6 at 12:41 PM
	Scholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of Neurology finance.yahoo.com - October 3 at 8:16 AM
	Scholar Rock Presents Exploratory Responder Analysis on Efficacy Data from the Apitegromab TOPAZ Phase 2 Trial at the Child Neurology Society Annual Meeting finance.yahoo.com - September 30 at 2:03 PM
	Scholar Rock Announces Issuance of U.S. Patent Protecting SRK-181, an Inhibitor of TGFβ1 Activation finance.yahoo.com - September 28 at 7:48 PM

	Scholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual Congress finance.yahoo.com - September 23 at 1:45 PM
	Scholar Rock to Present at the 2021 Cantor Virtual Global Healthcare Conference finance.yahoo.com - September 22 at 5:15 PM
	Shareholders have faith in loss-making Scholar Rock Holding (NASDAQ:SRRK) as stock climbs 9.0% in past week, taking one-year gain to 194% nasdaq.com - August 16 at 5:47 PM
	Scholar Rock Appoints Caryn Parlavecchio as Chief Human Resources Officer finance.yahoo.com - August 16 at 5:47 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRK finance.yahoo.com - August 14 at 2:37 AM
	Scholar Rock Reports Second Quarter 2021 Financial Results and Highlights Business Progress finance.yahoo.com - August 10 at 8:37 PM
	Scholar Rock Holding Corporation (SRRK) Reports Q2 Loss, Lags Revenue Estimates finance.yahoo.com - August 10 at 8:37 PM
	Scholar Rock Holding (NASDAQ:SRRK) shareholder returns have been solid, earning 173% in 3 years finance.yahoo.com - August 10 at 3:36 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRK finance.yahoo.com - August 9 at 1:04 AM
	Scholar Rock to Present at the 2021 Wedbush PacGrow Healthcare Conference finance.yahoo.com - August 5 at 6:00 PM
	Scholar Rock President, CEO Tony Kingsley Leaves >SRRK marketwatch.com - August 3 at 1:32 PM
	Scholar Rock Shares Fall After Departure of CEO Kingsley >SRRK marketwatch.com - August 3 at 1:32 PM
	Scholar Rock Announces Leadership Change finance.yahoo.com - August 3 at 8:32 AM
	Earnings Preview: Scholar Rock Holding Corporation (SRRK) Q2 Earnings Expected to Decline finance.yahoo.com - July 30 at 6:59 PM
	Scholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress finance.yahoo.com - June 18 at 8:21 AM
	Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA ... businesswire.com - June 12 at 1:37 AM
	Scholar Rock Up After Promising Data in Spinal Muscular Atrophy marketwatch.com - June 11 at 8:33 PM
	Scholar Rock: Data Shows Potential of Apitegromab in Spinal Muscular Atrophy marketwatch.com - June 11 at 10:33 AM
	Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting finance.yahoo.com - June 11 at 10:33 AM
	Scholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical ... businesswire.com - June 7 at 9:45 AM
	Scholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical Care Meeting finance.yahoo.com - June 7 at 9:45 AM

	Scholar Rock to Present at Upcoming Healthcare Conferences in June finance.yahoo.com - May 27 at 9:32 AM
	Scholar Rock Rings The Closing Bell nasdaq.com - May 24 at 8:09 PM
	Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy finance.yahoo.com - May 24 at 8:09 PM
	Scholar Rock to Present Trials in Progress Poster... benzinga.com - May 19 at 10:47 PM
	Scholar Rock to Present Trials in Progress Poster for SRK-181 DRAGON Phase 1 Clinical Trial at the American Society of Clinical Oncology Annual Meeting finance.yahoo.com - May 19 at 5:46 PM
	Analysts Have Been Trimming Their Scholar Rock Holding Corporation (NASDAQ:SRRK) Price Target After Its Latest Report nasdaq.com - May 16 at 2:53 PM
	Scholar Rock Reports First Quarter 2021 Financial Results and Highlights Business Progress finance.yahoo.com - May 13 at 9:32 AM
	Does Scholar Rock Holding (NASDAQ:SRRK) Have A Healthy Balance Sheet? finance.yahoo.com - May 12 at 2:30 PM
	Scholar Rock Announces Publication of Phase 1 Clinical Trial Data Evaluating Apitegromab in Healthy Volunteers in the Journal Advances in Therapy finance.yahoo.com - May 11 at 5:25 PM
	Is Scholar Rock Holding (NASDAQ:SRRK) Using Debt Sensibly? nasdaq.com - May 10 at 4:22 PM
	Scholar Rock Holding Becomes Oversold (SRRK) nasdaq.com - May 4 at 3:38 PM
	Earnings Preview: Scholar Rock Holding Corporation (SRRK) Q1 Earnings Expected to Decline finance.yahoo.com - April 29 at 1:55 PM
	The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout msn.com - April 27 at 8:41 AM
	Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Inhibitors of Myostatin Activation finance.yahoo.com - April 26 at 5:57 PM
	Scholar Rock Stock Shows Market Leadership With Healthy Jump To 83 RS Rating finance.yahoo.com - April 21 at 8:18 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRK finance.yahoo.com - April 12 at 12:18 PM
	Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting finance.yahoo.com - April 10 at 12:49 PM
	Mid-Day Market Update: Crude Oil Rises Over 2%; Scholar Rock Shares Plunge markets.businessinsider.com - April 6 at 5:23 PM